S0142 Colistimethate sodium, inhalation solution administered through dme, concentrated form, per mg
Billable / valid for submission HCPCS Release 2026Q3
Short description: Colistimethate inh sol mg
Version history
| Release | Valid from | Valid to | Description | Billable |
|---|---|---|---|---|
| 2026Q3 | 2026-07-01 | current | Colistimethate sodium, inhalation solution administered through dme, concentrated form, per mg | yes |
Related codes in S01
- S0104 Zidovudine, oral, 100 mg
- S0106 Bupropion hcl sustained release tablet, 150 mg, per bottle of 60 tablets
- S0108 Mercaptopurine, oral, 50 mg
- S0109 Methadone, oral, 5 mg
- S0117 Tretinoin, topical, 5 grams
- S0119 Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code)
- S0122 Injection, menotropins, 75 iu
- S0126 Injection, follitropin alfa, 75 iu
- S0128 Injection, follitropin beta, 75 iu
- S0132 Injection, ganirelix acetate, 250 mcg
- S0136 Clozapine, 25 mg
- S0137 Didanosine (ddi), 25 mg
- S0138 Finasteride, 5 mg
- S0139 Minoxidil, 10 mg
- S0140 Saquinavir, 200 mg
- S0145 Injection, pegylated interferon alfa-2a, 180 mcg per ml
- S0148 Injection, pegylated interferon alfa-2b, 10 mcg
- S0155 Sterile dilutant for epoprostenol, 50 ml
- S0156 Exemestane, 25 mg
- S0157 Becaplermin gel 0.01%, 0.5 gm